Back to today’s briefing

Story perspectives

AI-Driven Drug Discovery: $1 Billion Hopes Amid Doubts

1/4/2025

50 8

Summary

Story summary

The fusion of artificial intelligence and biotechnology is set to transform drug discovery. Xaira Therapeutics, a newcomer in the field, has already raised an impressive $1 billion by harnessing generative AI to create synthetic proteins. Yet, amidst this excitement, doubts linger about AI's potential to overcome the daunting challenge of high drug failure rates in clinical trials.

1 of 1

Story summary

The fusion of artificial intelligence and biotechnology is set to transform drug discovery. Xaira Therapeutics, a newcomer in the field, has already raised an impressive $1 billion by harnessing generative AI to create synthetic proteins. Yet, amidst this excitement, doubts linger about AI's potential to overcome the daunting challenge of high drug failure rates in clinical trials.